Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
ViroMissile, Inc.
MacroGenics
M.D. Anderson Cancer Center
Blueprint Medicines Corporation
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
3B Pharmaceuticals GmbH
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
TopAlliance Biosciences
Shanghai PerHum Therapeutics Co., Ltd.
Shanghai PerHum Therapeutics Co., Ltd.
Taiho Pharmaceutical Co., Ltd.
Xencor, Inc.
DNAtrix, Inc.
BioEclipse Therapeutics
Celon Pharma SA
Adaptimmune
Ipsen
Quadriga Biosciences, Inc.
Genzada Pharmaceuticals USA, Inc.
Ascentage Pharma Group Inc.
Seagen Inc.
TG Therapeutics, Inc.
CytoMed Therapeutics Pte Ltd
Merrimack Pharmaceuticals
Mayo Clinic
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NYU Langone Health
Case Comprehensive Cancer Center